College of Medicine Archives | º£½Çֱ²¥ News Central Florida Research, Arts, Technology, Student Life and College News, Stories and More Fri, 02 Oct 2026 20:39:54 +0000 en-US hourly 1 https://wordpress.org/?v=7.1.2 /wp-content/blogs.dir/20/files/2019/05/cropped-logo-150x150.png College of Medicine Archives | º£½Çֱ²¥ News 32 32 Why Do We Celebrate UCF Space Week? Because Discovery Starts Here /news/why-does-ucf-celebrate-space-week/ Thu, 01 Oct 2026 13:30:18 +0000 /news/?p=149472 Space has always inspired what Knights do. The same unstoppable spirit that launched UCF still drives us — to challenge, lead and dare to explore the unknown.

]]>
Landing humans on the moon was just a dream when UCF was founded in 1963. But we dared to believe — developing the talent and inventing the technologies to make it reality. That same spirit still drives us today.

We are America’s Space º£½Çֱ²¥. And we celebrate UCF Space Week to honor our origin as we dare to build what’s next.

UCF student adjusts equipment on a large telescope at night, surrounded by cables and machinery, with a starry sky in the background.
UCF Space Week Oct. 25-30, 2026

Where Global Leaders Unite to Forge the Future of Space


With world-renowned faculty, hands-on learning experiences and a location less than an hour from Florida’s Space Coast, UCF continues to prove why it’s America’s Space º£½Çֱ²¥ — where education, industry and exploration unite to shape the future of space.

Oct. 25 marks the start of the second UCF Space Week, a university-wide celebration of all the ways Knight Nation boldly pushes space forward. The observance highlights UCF’s vital role in advancing space research, supporting Florida’s fast-growing space economy, and preparing the next generation of explorers, engineers, and entrepreneurs.

Here are a few key reasons why we celebrate UCF Space Week and how SpaceU is launching the next era of space innovation.

Founded to fuel the space industry, UCF remains a launchpad for those who dare to dream beyond Earth.

A Legacy in Fueling the Space Industry’s Talent Pipeline

When the university first opened in 1963, landing humans on the moon was a dream that seemed out of reach. Yet UCF dared to believe — and take action — by supplying talent and research to the nearby space industry based on the Space Coast just 35 miles east. UCF’s purpose has only grown stronger more than six decades later as space exploration fuels transformative innovation here on Earth.

UCF students can study 35+ space-related degrees, including engineering, science, medicine and more.

Every year, thousands of students gain real-world experience, conduct interdisciplinary research and participate in programs — including the aerospace medicine program — directly connected to industry, preparing them for in-demand roles across the space sector.

The university’s excellence in providing talent is supported by data, as the American Society of Engineering Education consistently ranks UCF in the top five nationally for awarding bachelor’s degrees in (2025):

Advancing Research That Reaches New Frontiers

When visionaries look to the future, they also look to UCF — a leader in space research, innovation and education with 14 experiments sent to space aboard commercial rockets since 2016. UCF Space Week spotlights these breakthroughs, connecting the community with the pioneering work happening right on campus.

 By studying how space conditions accelerate aging, UCF researchers could help protect astronauts and inform treatments for age-related diseases on Earth.

Studying Aging in Space

Researcher: Professor Michal Masternak, College of Medicine
Project: Masternak and his team study how the extreme conditions of space affect human aging and health. By simulating microgravity and space radiation, the researchers identified molecular changes associated with accelerated aging, offering insights that could help protect astronauts on long-duration missions and inform future therapies for age-related diseases on Earth.

 UCF researchers are leading NASA's Lunar-VISE mission, which will send a robotic lander and rover to explore the moon's mysterious Gruithuisen Domes for the first time.

Unlocking Lunar Resources

Researchers: Planetary Geologist and Associate Professor Kerri Donaldson Hanna and Interim Department Chair of Physics and Associate Professor Adrienne Dove
Project: Donaldson Hanna and Dove are leading NASA’s Lunar-VISE (Lunar Vulkan Imaging Spectroscopy Explorer) mission, which aims to uncover clues about an unexplored part of the moon and potential insight for deeper space exploration.

UCF researchers are developing photonics technology to help future space telescopes detect Earth-like planets and search their atmospheres for signs of life.

Detecting Habitable Worlds

Researcher: Professor Stephen Eikenberry, College of Optics and Photonics
Project: Eikenberry and his team are developing advanced photonics technology to help future space telescopes detect Earth-like planets hidden by the brightness of nearby stars. The NASA-funded project could improve scientists’ ability to directly observe potentially habitable worlds and search their atmospheres for signs of life.

29% of Kennedy Space Center employees are UCF alums.

Building Partnerships That Propel Discovery

UCF Space Week highlights these crucial collaborations with support from Blue Origin, KPMG, Lockheed Martin, Verizon, Space Florida and SpaceX.

At the heart of UCF’s success is collaboration. The university works closely with NASA, government agencies, private companies, and research institutions to create opportunities that bridge education, research, and real-world application. These partnerships help students gain experience and industry insight while advancing technologies that will define the next phase of space exploration.

On Sept. 9, UCF partnered with the U.S. Space Force’s innovation enterprise to launch the . The effort strengthens connections between government, academia, industry and entrepreneurs to help promising ideas move faster from research to real-world capability.

UCF is also helping space‑related research, innovation and workforce development across through the Florida Space Research Consortium. Alain Berinstain, who joined UCF in January as director of the Florida Space Institute, now leads the eight-university initiative — underscoring UCF’s leadership and expertise in this evolving field.

Launched in Spring 2026, UCF's online space MBA is powering the next generation of economic development.

Powering Florida’s Space Economy

Space is no longer just a frontier — it’s the future. With the global space economy projected to reach $1.8 trillion by 2035, UCF is preparing the visionaries who will fuel discovery and shape that growth.

Now expanding its impact into the business of space, UCF is helping lead the business of space under the direction of Space Commercialization and Strategy Program Director Zaheer Ali . His work is building a pipeline of leaders ready to drive innovation, strengthen national security and unlock opportunities that will advance humanity’s future beyond Earth.

Reaching for What’s Next

UCF Space Week isn’t just about looking back at past achievements — it’s about imagining what comes next. With a legacy built on exploration and a community fueled by curiosity, UCF continues to inspire students and researchers to reach higher, think bolder and push the boundaries of what’s possible.

Because at UCF, space isn’t the final frontier — it’s just the beginning.

]]>
UCF student adjusts equipment on a large telescope at night, surrounded by cables and machinery, with a starry sky in the background. UCF Space Week Oct. 25-30, 2026 Why We Celebrate UCF Space Week_2026_1 Why We Celebrate UCF Space Week_2026_2 Why We Celebrate UCF Space Week_2026_3 copy Why We Celebrate UCF Space Week 2026_4 Why We Celebrate UCF Space Week 2026_5 Why We Celebrate UCF Space Week 2026_6_2 Why We Celebrate UCF Space Week_2026_7
UCF Researcher Investigates Mechanisms of Nicotine Addiction /news/ucf-researcher-investigates-mechanisms-of-nicotine-addiction/ Fri, 25 Sep 2026 13:00:14 +0000 /news/?p=155467 Through a National Institutes of Health grant, College of Medicine Assistant Professor Cali Calarco is investigating how brain cells respond to nicotine and influence behavior.

]]>
UCF assistant professor and researcher , with the College of Medicine‘s Burnett School of Biomedical Sciences, is exploring how nicotine affects brain cells, providing insights that could ultimately help improve treatments for addiction.

Through a nearly five-year, $943,000-plus grant from the National Institutes of Health, Calarco’s lab is examining how neurons — nerve cells in the brain — and their molecules change when exposed to nicotine and other drugs. The goal is to understand how microscopic changes in the brain eventually influence behavioral decisions, including those associated with addiction.

“We want to understand what’s really influencing the neuron,” says Calarco, who began work on this project in 2024 as a postdoctoral scholar at the º£½Çֱ²¥ of Maryland, Baltimore, before joining UCF in January as an assistant professor. “Which component is critical for the neuron function that leads to drug-seeking behavior?”

For this research, Calarco’s lab is focused on the nucleus accumbens, an area of the brain involved in reward, learning and behavior.

“I call it a little computer that integrates a lot of signals that come in relationship to reward learning from a lot of other parts of the brain to guide behavioral choices,” she says.

“We want to understand what’s really influencing the neuron. Which component is critical for the neuron function that leads to drug-seeking behavior?” — Cali Calarco, assistant professor

The nucleus accumbens contains multiple types of brain cells, and Calarco’s research examines how individual cell types respond to nicotine and other drugs. Her lab is particularly interested in mitochondria, the structures within cells that produce the energy they need to function. Recent studies suggest mitochondria may also play an important role in drug-seeking behavior.

“Mitochondria have been underappreciated in neurons previously,” she says. “Neurons are incredibly complex cells that do incredibly complex tasks, both electrically and chemically that require a ton of energy, so we knew they were really important. But mitochondria also influence how neurons communicate with each other. They’re super important for gene transcription and translation and for steroid hormone production.”

UCF Assistant Professor Cali Calarco stands with six researchers wearing lab coats in a biomedical sciences laboratory.
Assistant Professor Cali Calarco (left) with researchers in the Burnett School of Biomedical Sciences. Calarco’s research examines how brain cells respond to nicotine and how cellular changes may influence behaviors associated with addiction. (Photo courtesy of Cali Calarco)

By understanding addiction at the molecular level, researchers may ultimately be able to develop better treatments for substance use disorder.

“There aren’t that many substance use disorder treatments, and the ones available only work for a subset of people,” she says. “There is room for improvement in nicotine use disorder therapies, and new pathway targets may provide more effective treatments with fewer side effects.”

Nicotine use has persisted even as the products used to consume it have changed. Calarco compares the trend to a game of whack-a-mole, with new nicotine products gaining popularity as older ones decline. While cigarette smoking has declined, consumers now have access to products such as e-cigarettes and nicotine pouches placed between the lips and gum. According to data from the FDA and CDC’s 2025 National Youth Tobacco Survey, nicotine pouch use nearly quadrupled among U.S. youth and young adults between 2022 and 2025.

While her research is focused on nicotine, Calarco says her findings could have implications for other substances and even social media addiction.

Calarco earned her doctorate in neuroscience from Yale º£½Çֱ²¥ before conducting postdoctoral research at the º£½Çֱ²¥ of Maryland, Baltimore, where she studied mitochondria and cocaine-seeking behavior. She joined the UCF College of Medicine’s Burnett School of Biomedical Sciences in January 2026.


Research reported in this publication was supported by the National Institute on Drug Abuse of the National Institutes of Health under award number K01DA061048. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. 

]]>
Calarco Lab Team UCF Assistant Professor Cali Calarco, left, with researchers in the Burnett School of Biomedical Sciences. Calarco’s research examines how brain cells respond to nicotine and how cellular changes may influence behaviors associated with addiction. (Photo provided by Cali Calarco)
UCF Researcher Identifies 10 Potential Treatments for Rare Nerve Tumor in Children /news/ucf-researcher-identifies-10-potential-treatments-for-rare-nerve-tumor-in-children/ Wed, 23 Sep 2026 14:00:59 +0000 /news/?p=155281 Using artificial intelligence-generated data, Pegasus Professor Cristina Fernández-Valle and her team are screening existing FDA-approved drugs for their potential to treat schwannoma tumors.

]]>

What if an existing drug could be repurposed to treat a rare disease?

That’s the question UCF researchers are exploring with the help of artificial intelligence (AI) to find a cure for rare nerve tumors that can cause paralysis, hearing and balance loss.

Led by UCF College of Medicine Pegasus Professor Cristina Fernández-Valle, the team is investigating whether medications already approved by the U.S. Food and Drug Administration for other conditions could be swiftly repurposed to treat schwannoma tumors.

The researchers have narrowed a field of about 200 potential drugs to 10 of interest, with three emerging as the most favorable targets.

Their goal is to find new treatment options for patients with Neurofibromatosis type 2 (NF2)-related schwannomatosis. The genetic disorder causes benign tumors to develop on nerves throughout the body and head. As the tumors grow, they can damage nerves responsible for movement and sensation, including those needed to hear and balance.

The disease affects about one in 25,000 newborns worldwide, according to the Children’s Tumor Foundation, with symptoms often appearing during adolescence and early adulthood. When diagnosed in children, the disorder can be severe and may require multiple surgeries during puberty to reduce tumor size and prevent further loss of function. The Children’s Tumor Foundation is supporting UCF’s research with a $280,020 grant.

“The Children’s Tumor Foundation was critical to us because they fund the exploratory research that helps advance science,” Fernández-Valle says. “All of this foundational data is needed to attract the additional support needed to demonstrate a treatment holds real promise.”

A UCF student uses a pipette while UCF Professor Cristina Fernández-Valle observes him in a research lab.
Pegasus Professor Cristina Fernández-Valle observes UCF College of Medicine M.D./Ph.D. candidate Ethan Hass as he prepares medication samples for efficacy testing.

Looking for Treatments Beyond Surgery

Schwann cells normally help repair nerves and transmit electrical signals throughout the nervous system. In patients with NF2, however, these cells can form visible tumors that cause chronic pain and neurological issues depending on the affected spinal or cranial nerve.

Current treatments center on surgery and radiation, but removing these tumors can be challenging without damaging critical nerves, including those that affect hearing. Surgery also is not curative, as tumors can regrow.

That’s why the research team is looking beyond surgery to potential drug therapies.

While schwannomas are not cancerous, the researchers believe some cancer-fighting drugs may help patients with NF2.

The research began with an AI model called TxGNN, developed by Marinka Zitnik’s laboratory at Harvard Medical School. The model analyzes data and biological mechanisms across thousands of diseases and FDA-approved drugs to identify potential treatments for a queried disease.

“It essentially generates a map for a disease or condition, like schwannomas, and finds overlaps in targeting similar pathways or related diseases,” says Ethan Hass, a UCF College of Medicine M.D./Ph.D. candidate working in the lab.

Researchers at Sage Bionetworks used the TxGNN model to identify about 200 FDA-approved medications that could potentially benefit schwannoma patients. Fernández-Valle’s team then used an innovative imaging system to observe how each drug affected human schwannoma cells.

Using a camera inside a microscope, the team watched how schwannoma cells in a dish reacted to small amounts of each drug. The most promising candidates – medications currently used to treat diseases as varied as lung cancer and acne – stopped tumor cell growth by impacting different cellular mechanisms.

A Step Towards Personalized Treatment

The research continues.

The UCF scientists are determining therapeutic doses for the most promising drugs using patient-derived schwannoma cells. They’re also studying how the drugs affect the tumor growth pathways at the RNA level.

Ultimately, the researchers hope their findings will help identify drug combinations tailored to individual patients. Complicated and understudied genetic conditions like NF2-related schwannomatosis often require treatments that address multiple targets, Fernández-Valle says.

“I think this work is encouraging, and I’d say like with many cancers, you need a cocktail of drugs to treat it,” she says. “I think what we’re doing here is helping to identify some of the ingredients you might need to make an effective cocktail.”

UCF Professor Cristina Fernández-Valle poses with four student researchers in a lab.
From left: Pegasus Professor Cristina Fernández-Valle, biomedical sciences undergraduate students Alfonso Aviles and Amanda Nunez-Ferreira, materials science and engineering doctoral candidate Alex Sutton and M.D./Ph.D. student Ethan Hass.

From Lab Bench to Patient Bedside

The project also provides UCF students with the opportunity to participate in research that can make a real-world impact.

Since joining Fernández-Valle’s lab, Hass says his interest in caring for patients with difficult neurologic conditions has grown.

“As an M.D./Ph.D. student, translation is the magic word for me,” he says. “I absolutely love seeing research that can be brought from the bench to the bedside. I want to be that bridge between patients and research.”

]]>
Cristina-Valle and Ethan-Hass_ Schwannoma research Cristina Valle and students_ Schwannoma research
UCF Discovery on Immune Cells Could Illuminate Pathways to New Treatments /news/ucf-discovery-on-immune-cells-could-illuminate-pathways-to-new-treatments/ Tue, 15 Sep 2026 13:35:18 +0000 /news/?p=155242 The findings mark an important first step in understanding how to modify T cells to create future treatments for cancers, infections and autoimmune disorders.

]]>

For generations, scientists have looked to the genetics inside immune cells for ways to improve how the body fights disease.

Now, a research team led by UCF College of Medicine assistant professor Hung Nguyen is examining an understudied molecule within T cells as a pathway to treatments for cancers, infections and autoimmune disorders.

Their study, recently published in Trends Open, focuses on transfer RNA (tRNA), molecules within cells that help build proteins to energize themselves. Nguyen is working to chemically modify these molecules to expand the function of T cells, specialized white blood cells that are the cornerstone of the body’s immunity. The findings represent an important first step toward understanding whether tRNA can eventually be manipulated to fine-tune immune responses to multiple diseases.

T cells play a key role in identifying and killing invasive abnormalities within the body, including infections and cancers. The cells also allow the body to remember previous infections and respond more quickly if re-infected or attacked, says Cuong Pham, a biomedical sciences Ph.D. candidate working under Nguyen who served as the study’s first author.

“T cells are already central to modern medicine,” Pham says. “At the same time, we still do not fully understand all the molecular mechanisms that determine how T cells become activated to respond. Our review brings together emerging evidence showing that tRNA modifications can help support and regulate these responses.”

This discovery comes as a continuation of Nguyen’s efforts to find innovative immunotherapies for a wide range of conditions. An early career researcher, Nguyen earned a “Reach for the Stars” award from UCF in 2024 for his potential for significant impact.

Man in white lab coat, wearing glasses, holds dropper with red liquid in right hand as another man in lab coat observes.
Biomedical sciences Ph.D. candidate Cuong Pham pipettes a mixture of cells and modifying compounds to test the experimental treatments.

An Innovative Approach to Immunity

UCF’s research is the first time scientists have tested modifying mitochondrial tRNA in T cells to change their behavior, Nguyen says.

“We are looking at the tRNA modification within T cells that have never been reported,” he says. “In the field, tRNA modification is not so new. For T cells, researchers have been focusing on all the other parts before now.”

The discovery came as a result of an active project in Nguyen’s lab that is examining how diet can affect the immune response in  cancer patients.

“I wouldn’t say we found this by accident, but we were very lucky,” Nguyen says. “We examined the mitochondria of the T cell, and we kept looking at all the different layers and targets and then we arrived at the tRNA.”

Studying tRNA is challenging because the molecules are short and densely packed, making them difficult to analyze and modify, Nguyen says.

So the UCF team used cutting edge technology called liquid chromatography-tandem mass spectrometry (LC-MS/MS). The highly sensitive technique separates massive quantities of molecules in a sample and then identifies and measures them.

“It is very new for use in detecting tRNA, and it was so important for us to see how everything worked,” Nguyen says.

Dr. Nguyen stands in center, surrounded by six of his students in courtyard of College of Medicine
UCF College of Medicine assistant professor Hung Nguyen (front row, second from left) and his lab team. (Photo by Eddy Duryea ’13)

Results Could Impact Other Immunity Research

In the study, the team genetically engineered the tRNA to give T cells signals to activate against specific disease cells.

While the research is still in its early stages, Nguyen says that they have already identified ways to modify T cells to pinpoint and fight melanoma, colon cancer and lupus.

Nguyen says he hopes his new findings will provide a way for other researchers to create new immunotherapies.

“We want to share these ideas with the greater science community and bring everyone together to help us validate them and ultimately benefit more people,” he says.

Drawn to UCF for its opportunities for interdisciplinary research, Pham says he’s looking forward to being a part of what’s next in the College of Medicine’s immunology efforts.

“The next step is to move deeper into the mechanisms behind these observations,” Pham says. “Our lab has strong and ambitious research directions in immunometabolism. We want to understand how those changes in tRNA influence T cell metabolism and function, and whether specific pathways can eventually be targeted to ultimately help patients.”

Minh Tuyet Le Nguyen, a UCF postdoctoral scholar, and the Hanoi º£½Çֱ²¥ of Pharmacy in Vietnam also contributed to the research.


Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R01HL166820. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

]]>
Dr. Hung Nguyen and Cuong (24) Biomedical sciences Ph.D. candidate Cuong Pham pipettes a mixture of cells and modifying compounds to test the experimental treatments. Dr. Nguyen lab group shot-medicine-ucf College of Medicine UCF College of Medicine assistant professor Hung Nguyen (front row, second from left) and his lab team. (Photo by Eddy Duryea '13)
Med Student Driven to Create Hope Through Cancer Research Earns Inaugural Award /news/med-student-driven-to-create-hope-through-cancer-research-earns-inaugural-award/ Thu, 27 Aug 2026 15:14:42 +0000 /news/?p=154959 The winner of the inaugural Dean Deborah C. German, M.D. FIRE Impact Award came to UCF because of the College of Medicine’s focus on research.

]]>
UCF medical student Natalya Kramer lost her grandfather to lymphoma, inspiring her to pursue medicine with hopes of caring for cancer patients and their families.

That dedication and her passion for research recently earned Kramer the inaugural Dean Deborah C. German, M.D. FIRE (Focused Individualized Research Experience) Impact Award, an honor named after the founding dean of UCF’s College of Medicine who created the FIRE course, which requires every student to conduct a two-year research project.

German announced earlier this year that she is transitioning from her role and will remain at UCF for a year as an advisor to the president and provost on health affairs. FIRE leaders created the award to honor German’s legacy of scientific discovery as part of medical training, an educational component that makes UCF’s medical school unique nationally.

“I want our students to develop a spirit of inquiry. I want every UCF physician not to be afraid to seek answers to medicine’s unanswered questions.” — Deborah German, College of Medicine dean

“I want our students to develop a spirit of inquiry,” German told Kramer as she presented her with the award. “I want every UCF physician not to be afraid to seek answers to medicine’s unanswered questions.”

After earning an undergraduate degree the º£½Çֱ²¥ of South Florida, Kramer decided to attend UCF in part because the FIRE course was one reason she came to UCF.

“I wanted to combine research with clinical care,” she says.

Her FIRE project focused on glioblastoma, an aggressive brain cancer with a five-year survival rate of only 5% to 7%, according to the Mayo Clinic. Even if surgery, chemotherapy and radiation initially stop the cancer, it usually returns and becomes stronger. Kramer says she wanted to know why.

With support from her FIRE mentor, Kiminobu Sugaya, head of the College of Medicine’s neuroscience research division, she discovered that extracellular vesicles responsible for cell-to-cell communication may influence non-cancer cells to take on cancer-like properties.

Medical student Natalya Kramer (center, left) with UCF College of Medicine founding Dean Deborah German (center, right) and co-directors of the FIRE course Lane Coffee (left) and Robert Hines (right).

The new award goes to the student whose research shows the greatest potential impact to medicine and/or biomedical research. College of Medicine faculty and fellow students chose Kramer for the award during the FIRE Conference.

“It is our privilege to establish this award in honor of Dean German,” say Robert Hines and Lane Coffee, co-directors of the FIRE course. “When establishing this medical school, she realized the importance of rigorous scientific inquiry, and our students have benefited from — and will continue to benefit from — this course within the curriculum.”

]]>
2026-Dean’s-Research-FIRE-award,-Dr.-German-&-Natalya–(5) Natalya Kramer (left) with UCF College of Medicine founding Dean Deborah German (right).
FAA Executive Physician/Scientist Joins UCF Aerospace Medicine Team /news/faa-executive-physician-scientist-joins-ucf-aerospace-medicine-team/ Fri, 21 Aug 2026 13:00:08 +0000 /news/?p=154760 After 34 years with the FAA, Melchor Antuñano joins UCF to create a new aerospace medicine master’s degree and residency program, as well enhance safety for astronauts, pilots and flight passengers.

]]>

He’s an experienced skydiver, private pilot and scuba diver whose hero since childhood has been moon-walker Neil Armstrong. And now Melchor Antuñano is a UCF Knight.

After 34 years with the Federal Aviation Administration (FAA) — the longest term for any senior executive in the agency’s history — Antuñano has joined the College of Medicine’s team as a professor, and chief technologist and medical innovation officer. In these roles he’ll help design new procedures and technologies to keep astronauts, pilots and airplane passengers safer and help create a new UCF master’s degree in aerospace medicine and a residency program for aerospace medicine physicians. He’ll also teach across UCF colleges.

“Being part of this outstanding visionary team gives me the opportunity not only to help advance the field I love, but also to inspire, educate and mentor the next generation of physicians, scientists and innovators.” — Melchor Antuñano, UCF aerospace medicine medical innovation officer

Antuñano says a career in aerospace medicine has given him the “opportunity to continually learn, adapt and contribute to a specialty defined by innovation, exploration, and discovery.”

“Joining the UCF College of Medicine represents a new and exciting chapter in that journey,” he continues. “Being part of this outstanding visionary team gives me the opportunity not only to help advance the field I love, but also to inspire, educate and mentor the next generation of physicians, scientists and innovators.”

He is the newest leader to join UCF’s new Center for Aerospace and Extreme Environments Medicine , a multidisciplinary center includes faculty experts in medicine, engineering, computer science, psychology, arts and educational leadership who will work together to research and develop new technologies for keeping space travelers healthy as well as soldiers on military missions, deep sea explorers, and mountain climbers.

“Dr. Antuñano brings to UCF an extraordinary combination of operational experience, scientific leadership, innovation and a lifelong commitment to aerospace medicine,” says Emmanuel Urquieta, vice chair for aerospace medicine and director of CASEEM. “For more than three decades, he helped shape aerospace medicine and safety at the national and international levels. Having someone of his caliber join our team is transformative as we build a comprehensive aerospace medicine program that integrates clinical care, education, research and technology development.”

A Resourceful First Responder Before Medical School

Born in Mexico City, Antuñano had two dreams as a child: to be a doctor and fly airplanes. Before entering medical school at the National Autonomous º£½Çֱ²¥ of Mexico School of Medicine, he volunteered with the Red Cross and the country’s rescue squad as a paramedic, rescue worker and EMT. He couldn’t afford to buy a red emergency light for his car. So he made one using a pot.

“My parents always instilled in my sisters and me the importance of doing our best, persevering in the face of adversity, planning ahead and learning from our mistakes,” he says. “I learned from my parents the importance of being kind, fair and respectful to everybody.”

He learned about aviation medicine during medical school and volunteered at the Mexican Government’s National Center of Aviation Medicine, where he learned about aviation physiology (including altitude chamber operations), human factors in aircraft accident investigation and pilot medical certification.

Melchor Antuñano flying in a biplane
Melchor Antuñano flying in a biplane. (Photo courtesy of Melchor Antuñano)

Impact Fueled by Taking Initiative

Next came residency. Antuñano says he came to America because the only civilian aerospace medicine residency program was at Wright State º£½Çֱ²¥ School of Medicine in Dayton, Ohio.

He learned about this program by writing letters to senior U.S. federal government officials — including then President Ronald Reagan — inquiring where to pursue postgraduate training in aviation medicine in the U.S. He was accepted into the residency.

“That opportunity allowed me to pursue my professional dream and meet aerospace medicine physicians from all over the world,” he says.

Antuñano also earned a master’s in aerospace medicine at Wright State. His research was using a portable head cooling system to protect U.S. Air Force personnel from heat exposure. He built his lab in the kitchen of the residents’ lounge. He turned up the heat, then added oil and air heaters to create a thermal chamber. His experimental subjects were his classmates. He earned the Aerospace Medical Association’s Young Investigator Award for his initiative.

Melchor Antuñano
Melchor Antuñano (left) with astronaut Buzz Aldrin. (Photo courtesy of Melchor Antuñano)

After residency, he received a two-year postdoctoral research fellowship from the National Research Council of the U.S. National Academy of Sciences, Engineering and Medicine at the U.S. Air Force School of Aerospace Medicine. After that, he was hired as a contract scientist for the school to work on personal cooling technology for individuals wearing nuclear, biological and chemical protective suits.

Antuñano joined the FAA in 1992 and served as manager of the Medical Education Division and the Medical Certification Division at the agency’s Civil Aerospace Medical Institute (CAMI) in Oklahoma City. The institute is responsible for medically certifying that the nation’s pilots are physically fit to fly, training the physicians who perform the physical exams in the U.S. and in 90 countries worldwide, and conducting safety-related aerospace medicine and human factors research. He became CAMI’s director in 2001 and retired earlier this year as the longest serving director in history.

Steering the Future of Aerospace Medicine at UCF

“A leader has the responsibility to make more leaders,” he says. “Look for stars in the making — encourage them, support them and help turn them into future leaders.” — Melchor Antuñano, UCF aerospace medicine medical innovation officer

As the commercial space industry expands and humans prepare for longer missions to the moon, Mars and beyond, UCF’s College of Medicine is charting a new frontier in healthcare. The goal: explore how factors such as microgravity, radiation and isolation impact the human body in space and how that knowledge can drive innovation into diagnostics, treatment and disease prevention for patients on Earth.

As part of that effort, the aerospace medicine team is developing courses for students across the university and building a lab that will design, create and test the next generation of medical equipment to keep space travelers healthy. The team just opened the UCF Aerospace Medicine Clinic to provide medical certification exams for astronauts and pilots across the region.

Antuñano says he is excited about the future and his role in advancing aerospace medicine research while training the next generation of aerospace physicians.

“A leader has the responsibility to make more leaders,” he says. “Look for stars in the making — encourage them, support them and help turn them into future leaders.”

 

]]>
Melchor Antuñano_Flying Melchor Antuñano flying in a biplane. (Photo courtesy of Melchor Antuñano) Melchor Antuñano and Buzz Aldrin
UCF Scientist to Explore Precise Treatment Targeting Weak Spots in Lyme Disease Bacteria /news/ucf-scientist-to-explore-precise-treatment-targeting-weak-spots-in-lyme-disease-bacteria/ Thu, 13 Aug 2026 13:30:56 +0000 /news/?p=154614 Through her third consecutive NIH grant renewal, Mollie Jewett aims to “starve” Borrelia burgdorferi, preventing the tick-borne bacteria from spreading in humans and causing Lyme disease.

]]>
Triggered by a near-painless tick bite, Lyme disease causes severe pain and inflammation for more than 475,000 people in the U.S annually, according to the Centers for Disease Control.

Medicine can treat infections after people get sick, but UCF infectious disease expert Mollie Jewett is seeking to halt Borrelia burgdorferi bacteria, which causes Lyme disease, in its tracks without relying on general antibiotics. Her goal: “starve” the bacteria of the nutrients they need to function before they spread through the human body.

Jewett, professor and head of the Immunity and Pathogenesis Research Division at UCF’s College of Medicine, is supported by a recently renewed five-year, $2.5 million grant from the National Institutes of Health.

UCF infectious disease expert Mollie Jewett smiles while wearing a white lab coat in a research lab.
UCF infectious disease expert Mollie Jewett.

She is entering a third consecutive federally funded research cycle with $513,314 received this year. Jewett’s research builds upon more than a decade of discoveries that have narrowed the search for ways to stop B. burgdorferi from triggering Lyme disease, one of the nation’s most common vector-borne diseases. Her team includes a UCF undergraduate who occasionally struggled to walk because of pain from Lyme disease.

The disease is spread by blacklegged ticks that become infected after biting mammals or birds carrying the bacteria. The ticks are so small, humans often don’t notice they have been bitten. Symptoms include fever, chills, headache and fatigue, which often are misdiagnosed as a virus or the flu. Even after treatment, Lyme disease patients can face complications including nervous system and heart issues, severe fatigue and arthritic pain.

The disease is most commonly found in Maine to Virginia and in the upper Midwest but is spreading as suburban growth enters wildlife areas. Florida reports few cases of Lyme disease annually, but travelers who go to endemic areas like New England are at increased risk.

A New Approach to Battle Borrelia

UCF researchers are focused on how B. burgdorferi manages to survive and thrive as it spreads in ticks and mammals to humans.

“The bacteria need to adapt to two different environments, and so we want to know how it does that,” Jewett says. “We’re looking at what the bacteria eat and what it needs to survive. In our lab, we call Borrelia a wimpy pathogen because it can’t make a lot of the nutrients it needs on its own, and so it scavenges what it needs from wherever it is.”

Researchers examine a petri dish on an illuminated light box in a lab.
Mollie Jewett and her lab analyze the purification of a novel riboflavin-dependent protein important for Borrelia burgdorferi metabolism.

The first iteration of the NIH grant allowed the scientists to screen all of the bacteria’s genes that might be important for the infection. With the second grant, Jewett targeted three genes that appeared to play a role in spreading the infection from a bite on the skin to other parts of the human body.

“One of these three genes we found is important to the ability of the bacteria to consume riboflavin. We want to target this gene and see if we can starve the bacteria.” — Mollie Jewett, UCF infectious disease expert

Now they have focused on riboflavin, commonly known as vitamin B2, after discovering that B. burgdorferi salvages the vitamin from each host to sustain itself.

“One of these three genes we found is important to the ability of the bacteria to consume riboflavin,” Jewett says. “We know that riboflavin is a precursor for other cellular activities that are important to the metabolism of the bacteria. Essentially, we want to target this gene and see if we can starve the bacteria.”

If their theory is successful, it could lead to therapies specific to B. burgdorferi that would prevent successful bacterial infection by limiting its riboflavin uptake. An advantage of such potential treatments would be that patients don’t have to take general antibiotics that can also harm the body’s good bacteria and increase risks for antibiotic-resistant bacteria.

The UCF team is collaborating with Baylor º£½Çֱ²¥ scientists to trace exactly how riboflavin is used by the bacteria.

Researchers examine a petri dish on an illuminated light box in a lab.
Biomedical sciences doctoral student Anna Schulz ’25MS (left) uses genetic approaches to characterize Borrelia burgdorferi genes important for metabolizing vitamin B2. To accomplish this, Schulz and Jewett (right) examine bacterial colonies on solid medium plates.

Students Driving Discovery

Biomedical sciences doctoral student Anna Schulz ’25MS played a key role in pinpointing specific ways the bacteria use riboflavin to generate energy. She served as first author on a recent publication examining these processes, and says she’s looking forward to growing as a researcher in this next phase.

“As a first author, I took more ownership over the experiments and the writing process,” Schulz says. “[Jewett] was really great about letting me lead the project as a student. Borrelia is so unique, and there’s still so much we don’t know, and that’s what keeps me engaged with this research.”

“… I couldn’t treat it until years after I got infected. So, I truly care about finding new treatments for Lyme disease.” — Grace Easterling, UCF biomedical sciences student

Third-year biomedical sciences undergraduate Grace Easterling says she was drawn to Jewett’s lab because she previously developed Lyme disease and suffered tremendous joint pain. She was determined to find a way to protect others.

“It was something that, because we live in Florida, wasn’t caught early because it’s not as common,” Easterling says. “I struggled for a long time to get diagnosed, and I couldn’t treat it until years after I got infected. So, I truly care about finding new treatments for Lyme disease and understanding the bacteria.”

 


Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01AI099094. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

]]>
Mollie-Jewett Lyme disease research Mollie-Jewett_Anna-Schulz Biomedical sciences doctoral student Anna Schulz ’25MS uses genetic approaches to characterize Borrelia burgdorferi genes important for metabolizing vitamin B2. To accomplish this, Schulz and Jewett examine bacterial colonies on solid medium plates.
120 Students Join UCF to Become Physician Knights /news/120-students-join-ucf-to-become-physician-knights/ Tue, 04 Aug 2026 13:16:11 +0000 /news/?p=154542 Chosen from 5,422 applicants, the 120 new M.D. candidates received their undergraduate degrees from Yale, Vanderbilt, Notre Dame, Duke, Case Western and Emory in addition to UCF.

]]>
Pepi Dostal was inspired to enter medicine by his grandmother, a physician who cared for her village in the Czech Republic. Often paid with eggs or meat from her patients’ farms, she remains the village matriarch even after retirement.

“I saw what she means to her community,” says Dostal, who comes to UCF from the º£½Çֱ²¥ of Washington. “And I wanted to do the same thing for my community.”

Dostal was one of 120 new UCF College of Medicine students who received their white coats Monday in a traditional celebration that welcomes them as partners in healthcare.

Chosen from 5,422 applicants, the 120 new M.D. candidates received their undergraduate degrees from Yale, Vanderbilt, Notre Dame, Duke, Case Western and Emory in addition to UCF. They include scientists, artists, musicians, athletes, global volunteers and EMTs.

A group of students wearing white coats and posing for a photo
UCF’s M.D. Class of 2030 includes scientists, community volunteers, first responders, athletes and artists.

Monday was the 18th White Coat Ceremony in the history of the medical school, which celebrates its 20th anniversary this year. In his welcome, UCF President Alexander N. Cartwright described “what began as a bold vision on undeveloped land in Lake Nona has grown into a thriving Academic Health Sciences Campus and a community focused on improving lives.”

And he credited that growth to Deborah German, vice president for health affairs and founding dean, who has announced her transition from both roles. Monday was her last White Coat Ceremony.

“Dr. German helped transform an ambitious vision into the college you join today,” he told students, parents, faculty and staff. “Because of her leadership, hundreds of physicians have begun their careers here, thousands of patients have been served, and new partnerships, discoveries, and opportunities have taken shape across Lake Nona and our state. Dr. German, your remarkable legacy will always hold a special place at UCF.”

The Good Doctor

For every White Coat Ceremony, German has conducted the first class of medical school called “The Good Doctor – A UCF Tradition.”

Dean Deborah German conducts the first class of medical school at UCF — The Good Doctor, a UCF Tradition.
Dean Deborah German conducts the first class of medical school at UCF — The Good Doctor, a UCF Tradition.

She asks first-year students to imagine the person they love most in the world is seriously ill with an undiagnosed condition. What are the traits they want to see in the doctor caring for their beloved? As students name attributes, German writes each word on a blackboard that is displayed in the College of Medicine atrium for the entire year.

The class of 2030 suggested 38 traits, including humble, trustworthy, dedicated, knowledgeable, ethical, determined, compassionate, resilient and innovative.

“This is your contract with your faculty, friends, family, community and each other,” German said, pointing to the board. “Always remember, The Good Doctor lives in each of you. With the guidance of the faculty and your own hard work, you will become The Good Doctor.”

Nelson Jones with his family, including both parents who are nurses and inspired him to go into medicine.
Nelson Jones with his family, including both parents who are nurses and inspired him to go into medicine.

Inspired to Care for Others

As a UCF undergraduate, Nelson Jones earned the Order of Pegasus, the university’s top student honor. Today he is a physician-in-training. Both of his parents are nurses, and he described how their care of others – especially in communities of need – inspired him. So did the opportunities UCF provides.

“I’m feeling extremely grateful and excited,” he said after receiving his white coat. “This university has built me into the person I am and will continue to build me into the physician I strive to become.”

Vivian Silva-Dallenbach graduated from the º£½Çֱ²¥ of South Florida with degrees in biomedical sciences and astronomy. She chose UCF for medical school because of the college’s new aerospace medicine program. She’s researched how space flight affects the human body.

“Once I saw that UCF has an aerospace medicine program, I knew it was a match,” she says. “I’m particularly interested in women’s health and how we can provide specialized care for female astronauts.”

Dev Patel, another UCF alum, says his dreams are inspired by the College of Medicine’s founding dean. “I would like to take a page out of German’s book. She started with almost nothing to work with and she built something amazing here. So as we have such a long road in front of us, I’m hoping to follow in her footsteps and even have a fraction of the impact she did.”

]]>
UCF_-Class-of-2030-White-Coat UCF's M.D. Class of 2030 incudes scientists, community volunteers, first responders, athletes and artists. UCF_Class of 2030 White Coat_Deb German Dean Deborah German conducts the first class of medical school at UCF — The Good Doctor, a UCF Tradition. UCF_White Coat_Class of 2030_Nelson Jones Nelson Jones with his family, including both parents who are nurses and inspired him to go into medicine.
From the Clinic to the Cockpit: UCF Opens New FAA-Designated Clinic for Pilots /news/from-the-clinic-to-the-cockpit-ucf-opens-new-faa-designated-clinic-for-pilots/ Thu, 30 Jul 2026 17:34:48 +0000 /news/?p=154402 Through specially administered exams, UCF faculty member William “Ed” Powers and his team are helping pilots stay healthy and adhere to the medical standards the FAA requires for safe aircraft operation.

]]>

Minutes from one of the world’s most visited airports, UCF has opened a new clinic to help pilots meet Federal Aviation Administration (FAA) medical requirements to fly safely.

The new º£½Çֱ²¥ Aerospace Medicine Clinic at UCF Health Faculty Physician Practice in Lake Nona is led by William “Ed” Powers, chief medical officer of UCF’s and a certified aviation medical examiner.

Pilots operating civilian aircraft must have various levels of FAA medical certification depending on the type of aircraft. Commercial pilots must pass the exam every six months or each year.

“Flight safety depends on healthy pilots,” says Powers, who is certified to conduct the highest level of FAA exams. “That’s ultimately what we’re here to support.”

“Here at UCF, we are … connecting medicine, engineering, research and industry in ways few universities can.” — UCF President Alexander N. Cartwright

UCF President Alexander N. Cartwright says the clinic is an example of the university’s mission to educate talent, advance discovery and solve societal challenges that matter.

“The next era of flight will bring new demands on health and human performance,” Cartwright says. “Here at UCF, we are meeting those challenges by connecting medicine, engineering, research and industry in ways few universities can.”

What sets this clinic apart from others is its ability to more efficiently address the health needs of pilots thanks to a network of UCF College of Medicine faculty physicians, university officials say.

The clinic marked its opening with a ceremony today.

Assessing Safety and Minimizing Risk

Medical clearance for pilots is “all about risk,” Powers says. “The FAA has to assess the risk of a pilot experiencing a sudden incapacitation while flying. That’s really what these exams are focused on.”

For that reason, the UCF clinic will not focus on diagnosing disease, but on identifying and acting on any condition that might endanger pilot, crew and passenger safety.

In addition to a physical exam, pilots must pass hearing and vision tests, including demonstrating that they are not color blind. Airline pilots receive an electrocardiogram every year, while other pilots, like hobbyists, may receive an electrocardiogram if there is evidence of heart disease. Physicians also review medical history and discuss any health concerns that could affect flight safety.

Even manageable chronic conditions like high blood pressure can temporarily delay certification until the condition is treated, stabilized and controlled.

“When you’re flying an airplane, you don’t have the luxury of pulling over and waiting for help like if you’re a truck driver,” Powers says. “You must be aware at all times. If you’re responsible for an aircraft full of passengers, the FAA wants to minimize the chance of a sudden incapacitation.”

A Vast Network of Expertise

Complicated medical cases are referred to the FAA for further review, and pilots may need additional interventions to meet certification standards. That’s where the College of Medicine’s physician practice offers a distinct advantage, Powers says.

“We can guide pilots to the specialists and testing they need and help them get back on the path toward medical clearance.” — William “Ed” Powers, chief medical officer of the CASEEM

Unlike private clinics that do pilot certification exams, UCF offers multiple medical specialties under one roof and a team approach to care.

“We can guide pilots to the specialists and testing they need and help them get back on the path toward medical clearance,” Powers says.

Powers brings decades of expertise in space and aviation medicine. Before joining UCF, he was chief of NASA’s Medical Operations Branch, director of flight medicine for Axiom Space and director of the aerospace medicine residency program at the º£½Çֱ²¥ of Texas Medical Branch in Galveston.

Powers also worked inside the FAA as a supervisory medical officer. He says that experience gives him a firm understanding of what the FAA requires, making the process smoother for everyone.

“That means fewer delays, fewer mistakes in paperwork and a more efficient process for pilots whose livelihoods depend on getting certified,” he says.

William “Ed” Powers demonstrates part of a hearing test with a standardized patient. Pilots are assessed for hearing, vision, cardiovascular health and more to ensure pilot safety and eliminate the risk of sudden incapacitation.

Strengthening the Regional Aviation Ecosystem

Another UCF advantage: the clinic is only about 10 miles from Orlando International Airport, which welcomes 58 million travelers annually. So in addition to local aviators, pilots nationwide who travel to and through Orlando could easily schedule their certification exams at UCF.

“Clinics like UCF’s Aerospace Medicine Clinic [are] helping pilots, whether in space or on the ground, access the care and medical certification support they need to remain flight-ready.” — Lance Lyttle, CEO of the Greater Orlando Aviation Authority

The clinic will help strengthen the aviation training pipeline in one of the nation’s most active aerospace regions. This capability is especially important for local flight schools whose students may require guidance in navigating medical certification, return-to-flight concerns and the health demands of aviation careers.

“Central Florida’s aviation ecosystem is built on more than runways, terminals and launchpads,” says Lance Lyttle, CEO of the Greater Orlando Aviation Authority, which manages Orlando International and Orlando Executive airports. “It also depends on the people and services that keep aviation moving safely and efficiently. Clinics like UCF’s Aerospace Medicine Clinic complement that ecosystem by helping pilots, whether in space or on the ground, access the care and medical certification support they need to remain flight-ready.”

The clinic is embedded in Central Florida’s bustling travel hub with numerous satellite airports, including Kissimmee Gateway Airport and Orlando Sanford International Airport. Giving pilots another option to get cleared to fly strengthens the regional economy, says Shaun Germolus, director of aviation for the Kissimmee facility.

“The aviation industry in Central Florida provides a major economic impact to the region,” Germolus says. “The medical exams and certificates provided by the UCF Aerospace Medicine Clinic will be very valuable to ensure our aviation professionals are healthy and readily available to serve.”

Launching the Clinic

The clinic is starting with limited Thursday and Friday morning appointments to allow the team to refine operations before expanding. Helping coordinate those efforts is Camila Niebla ’26, a UCF health sciences graduate who now serves as the clinic’s aerospace medicine navigator.

Niebla discovered aerospace medicine by accident while exploring future career paths before applying to medical school.

“I didn’t even know aerospace medicine was a possibility,” she says. “I’ve always been interested in performance-driven medicine, like sports medicine, so this felt really exciting. It’s exciting to be part of something from the beginning and watch it grow.”

Part of a Larger Vision for Aerospace Medicine at UCF

The clinic is part of UCF’s , which is being developed as a comprehensive academic, clinical, research, education, and operational platform to support the future of aviation, commercial spaceflight, and human space exploration.

“This is about building the medical infrastructure required for the next era of flight, both on Earth and in space,” says Emmanuel Urquieta, vice chair for aerospace medicine at the UCF College of Medicine. “Our goal is to create a program that is not only academic, but operational and translational in nature — one that supports student pilots, flight schools, commercial aviation, spaceflight providers and the broader aerospace ecosystem.”

Schedule an Appointment

to learn more about FAA medical exams at UCF Health Faculty Physician Practice and schedule an appointment online.

]]>
FAA flight exam William “Ed” Powers demonstrates part of a hearing test with a standardized patient. Pilots are assessed for hearing, vision, cardiovascular health and more to ensure pilot safety and eliminate the risk of sudden incapacitation.
UCF Students, VA Doctor Develop AI Tool to Help Doctors Identify Chronic Pelvic Pain /news/ucf-students-va-doctor-develop-ai-tool-to-help-doctors-identify-chronic-pelvic-pain/ Tue, 28 Jul 2026 15:30:57 +0000 /news/?p=154477 Through a yearlong internship, two UCF undergraduates created an AI-assisted application that helps guide healthcare providers and patients towards accurate diagnosis of the source of chronic pelvic pain.

]]>
For millions of women living with chronic pelvic pain (CPP), finding answers can take far too long.

Studies have shown the condition affects nearly one in four women worldwide and is linked to dozens of potential disorders involving multiple organ systems. Yet many healthcare providers receive only limited training in diagnosing the source of pain, often leaving patients facing years of uncertainty, repeated testing and ineffective treatments before receiving the right diagnosis.

A yearlong collaboration between a UCF physician-scientist and two biomedical sciences undergraduate students aims to create a better environment for doctors and patients to reach an understanding together. Biomedical sciences students Sarah Gabriela Nieto Chavarro and second-year Juliana Dimetry interned with Georgine Lamvu, a UCF College of Medicine volunteer professor of obstetrics and gynecology, to transform years of international research into a practical tool to help clinicians evaluate patients more quickly and confidently.

The team is developing an AI-assisted clinical questionnaire application that guides physicians through a patient’s symptoms and identifies which organ systems and conditions should be examined. Rather than replacing a physician’s judgment, the application compiles patient histories quickly to help guide physicians toward making a clearer diagnosis.

From International Research to a Practical Tool

Despite the prevalence of CPP, many healthcare providers lack specialized training in diagnosing the underlying condition because symptoms often overlap with gastrointestinal, urinary, musculoskeletal and reproductive disorders.

“We’re hoping that this can become easy to use and can take a detailed medical history that could take an hour to get through down to just 5 to 10 minutes.” — Georgine Lamvu, volunteer professor and Orlando VA practitioner

“We’re hoping that this can become easy to use and can take a detailed medical history that could take an hour to get through down to just 5 to 10 minutes,” says Lamvu, who practices at the U.S. Department of Veterans Affairs Medical Center in Orlando and directs its gynecological surgery fellowship program and center. “That allows physicians to have a more efficient evaluation and spend more time with the patient.”

The center is a pioneering program designed to address the growing demand for specialized gynecologic care among women veterans. As the number of women veterans using VA healthcare services is expected to increase significantly, this fellowship and center aims to train highly skilled gynecologists to meet their healthcare needs within the VA system and beyond.

As part of that initiative, this project builds upon nearly five years of work led by Lamvu alongside an international coalition of physicians, researchers and patient advocacy groups.

Their research culminated in an international consensus called R U MOVING SOMe, an acronym that categorizes the broad range of symptoms associated with chronic pelvic pain and is the basis of the AI-tool Lamvu and her team developed.

Finding a Definitive Diagnosis

Lamvu says the team translated the clinical research into the logic behind a chatbot-style application that asks fewer than 20 targeted questions. Physicians enter a patient’s symptoms and history into the program, which then suggests the organ systems and conditions most likely responsible for the pain, helping clinicians focus their evaluation.

The team plans to expand the application beyond patient questionnaires by incorporating physical examination findings into the same scoring system. Ultimately, the researchers say they hope it can be used in any practice that serves women, but it may be years away from being realized.

“Physicians just need a way of processing all the information that comes from the patient to narrow it down to a differential diagnosis,” Lamvu says. “Right now, it’s all too common to see healthcare workers panic a little when they hear a patient has chronic pelvic pain because it’s considered a complex condition.”

Four people posing for a photo
Biomedical sciences students Sarah Gabriela Nieto Chavarro (left) and Juliana Dimetry (right) with Associate Professor of Medicine Kersten Schroeder (second from right), who was instrumental in facilitating the internship with UCF College of Medicine Volunteer Professor Georgine Lamvu (second from left) at the Orlando VA.

An Inspiring Internship

The students sifted through years of research and developed the logic for the AI in less than a year. Given the complexity of CPP and the vast amount of data, Lamvu says she is impressed by Dimetry and Nieto Chavarro.

“They learned valuable lessons, like if you see a problem that seems unsolvable to everyone else and that directly and negatively impacts patients, you have the power to do something about it,” she says. “These are experiences not every student gets to have, especially this early on in their life.”

Dimetry says she challenge intrigued her, and that she was drawn to the project for the opportunity to be at the forefront of medicine and emerging technology.

“I think that adapting the field of medicine to AI in ways such as this project is necessary to keep medicine growing and advancing,” she says. “I also saw how impactful this project could be if done successfully, and I wanted to be a part of that and make a difference,”

For Nieto Chavarro, who graduates Summer 2026, the experience showed her how to use technology to help deliver compassionate patient care.

“On a personal level, this experience has taught me to keep going and to never give up,” Nieto Chavarro says. “All of this has ultimately reinforced how essential it is to genuinely listen to patients so they feel safe and understood”

]]>
VA CPP research story with Dr. Lamvu (10) Biomedical sciences students Sarah Gabriela Nieto Chavarro (left), UCF College of Medicine Volunteer Professor Georgine Lamvu (second from left) and Juliana Dimetry (right) with Associate Professor of Medicine Kersten Schroeder (second from right), who was instrumental in facilitating the internship. (Photo by Eddy Duryea '13)